Skip to main content
Oriola Oyj logo

Oriola Oyj — Investor Relations & Filings

Ticker · OKDAV ISIN · FI0009014344 LEI · 549300UWB1AIR85BM957 HE Wholesale and retail trade
Open in API
Filings indexed 1,782 across all filing types
Latest filing 2023-10-31 Regulatory Filings
Country FI Finland
Listing HE OKDAV

About Oriola Oyj

https://www.oriola.com/

Oriola is a health and wellbeing company providing pharmaceutical distribution, wholesale, and advisory services in the Nordic market. The company connects pharmaceutical companies and health product suppliers with pharmacies, healthcare providers, veterinarians, and retailers. Core services include GDP-compliant supply chain management, warehousing, and specialized logistics like cold chain and vaccine distribution. The wholesale business offers a broad product range and leverages deep market knowledge to facilitate market access. Advisory services support clients throughout the product lifecycle with expertise in market entry, regulatory compliance, and commercial strategy, ensuring operational efficiency and customer value.

Recent filings

Filing Released Lang Actions
Oriola julkistaa strategian, taloudelliset tavoitteet ja vastuullisuusagendan: Lääkkeiden ja terveystuotteiden tukkukaupan johtava asiantuntija
Regulatory Filings Classification · 95% confidence The document is a press release from Oriola Oyj announcing their new corporate strategy, long-term financial targets, and sustainability agenda. It is under 5,000 characters and functions as an announcement of strategic updates rather than a full report itself. While it mentions that these items will be presented during the Q3 earnings call, the document itself is a regulatory announcement (Pörssitiedote) regarding corporate strategy. Given the specific nature of the announcement, it fits best under Regulatory Filings (RNS) as it serves as a general corporate disclosure.
2023-10-31 Finnish
10305101.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'OSAVUOSIKATSAUS 1.1.–31.3.2021' and 'Oriola Oyj:n osavuosikatsaus 1.1.–30.9.2023', which translates to 'Interim Report' or 'Quarterly Report' covering the period from January 1 to September 30, 2023. It contains detailed financial data including revenue, operating profit, adjusted operating profit, net profit, earnings per share, and segment performance. The document also discusses business environment, market conditions, and outlook for the year 2023. The length is about 15,000 characters, indicating a full report rather than a brief announcement. There is no indication that this is a certification, announcement of report publication, or a transcript. The content matches the definition of an Interim / Quarterly Report (IR) as it covers a period shorter than a full fiscal year with substantive financial data and analysis. 9M 2023
2023-10-31 Finnish
Oriola Oyj:n osavuosikatsaus tammi-syyskuulta 2023
Report Publication Announcement Classification · 95% confidence The document is a stock exchange release from Oriola Oyj announcing their interim report for the period January-September 2023. While the text provides a summary of financial highlights, it explicitly states in the 'Julkistamismenettely' (Publication procedure) section that this release is a summary and the full interim report is attached as a PDF. Following the 'Menu vs Meal' rule, since this is an announcement of a report rather than the full comprehensive financial report itself, it is classified as a Report Publication Announcement.
2023-10-31 Finnish
Oriola announces strategy, financial targets and sustainability agenda: The leading specialist in wholesale of pharmaceuticals and health products
Management Reports Classification · 99% confidence The document is a 'Stock Exchange Release' dated October 31, 2023, announcing Oriola's refined strategy, new long-term financial targets (for 2024-2026), and sustainability agenda. It details specific financial goals (sales growth, EBIT margin, ROE, dividend policy) and strategic pillars. Crucially, the last paragraph states: 'The strategy, financial targets and sustainability agenda will be presented today in connection with the Q3 2023 results webcast.' This indicates the document is an announcement accompanying or preceding the release of quarterly results, but the core content is strategic and forward-looking, not the detailed financial results themselves (which would be an ER or IR). Since it outlines new financial targets and strategy, it functions as a high-level strategic update often released alongside earnings. However, given the options, this type of strategic announcement, especially when tied to a specific period's results webcast, is often classified as an Investor Presentation (IP) if it were a deck, or an Earnings Release (ER) if it were just the numbers. Since it is a formal release detailing strategy and targets, and not just the raw earnings figures, it leans towards a strategic update. Given the context of financial targets and strategy presentation, 'Investor Presentation' (IP) is a strong candidate, although 'Earnings Release' (ER) is also plausible if the webcast is the primary event. Since the text is a formal release detailing strategy and targets, and not just the key financial highlights (ER), and it's not a presentation deck (IP), the best fit among the provided options for a strategic update tied to results is often the Investor Presentation category if it contains strategic depth, or the Earnings Release if it's the primary vehicle for the period's news. Given the focus on 'strategy' and 'financial targets' for the future (2024-2026), it is a strategic communication. If this were a full report, it would be 10-K/IR. As a strategic announcement, IP is the closest fit for strategic communication, but since it's a 'Stock Exchange Release' announcing targets alongside the Q3 results webcast, it functions similarly to an ER but with a heavy strategic component. I will classify this as an Investor Presentation (IP) because it details strategy and long-term targets, which is the core function of an IP, even if released via a stock exchange mechanism.
2023-10-31 English
Oriola julkistaa strategian, taloudelliset tavoitteet ja vastuullisuusagendan: Lääkkeiden ja terveystuotteiden tukkukaupan johtava asiantuntija
Regulatory Filings Classification · 93% confidence The document is titled 'Oriola julkistaa strategian, taloudelliset tavoitteet ja vastuullisuusagendan' (Oriola publishes strategy, financial targets, and sustainability agenda) and is explicitly labeled as a 'Pörssitiedote' (Stock Exchange Release) dated 31.10.2023. It details strategic direction for 2024-2026, new long-term financial targets (growth, profitability, dividend policy), and a sustainability agenda. This content is an announcement of strategic direction and financial outlook, not a full annual report (10-K), an interim report (IR), or a formal earnings release (ER) which typically focuses only on past period results. Since it announces strategic direction, financial targets, and ESG goals, it is a high-level corporate update. Given the options, it most closely aligns with a general corporate announcement that sets future direction, which often accompanies an earnings release but is distinct. However, the content is a comprehensive announcement of strategy and targets. It is not a Call Transcript (CT), Director's Dealing (DIRS), or a simple dividend notice (DIV). Because it announces key strategic and financial goals, it is a significant corporate update. Since there isn't a specific 'Strategy Announcement' code, we must choose the best fit. It is not a standard regulatory filing like 10-K or IR. It is a formal announcement of corporate direction and targets. This type of announcement, especially when tied to a specific reporting period (Q3 results mentioned at the end), often falls under the general category of a significant corporate update. Given the comprehensive nature of strategy, targets, and ESG, it is more substantial than a simple 'Report Publication Announcement' (RPA). It is a major corporate disclosure. The closest fit among the provided codes for a major strategic announcement that includes financial targets and ESG is often categorized under general regulatory filings if a specific strategy code is missing, or sometimes grouped with Investor Presentations (IP) if it were a slide deck, but here it is a press release. Since it is a formal stock exchange release detailing strategy and targets, and it is not a specific financial report, the most appropriate general category for a significant, non-standard filing is RNS (Regulatory Filings/General Announcements). However, if we interpret 'ER' (Earnings Release) as the announcement accompanying the results, this document contains the forward-looking strategy that often accompanies the ER. Given the focus on strategy and targets, and the fact that it is a formal press release, RNS is the safest fallback, but let's re-evaluate against ER. ER is usually just the numbers. This is strategy + targets. Since it is a formal stock exchange release, RNS is the most accurate fallback for a major, non-standard announcement.
2023-10-31 Finnish
Oriola Oyj:n osavuosikatsaus tammi-syyskuulta 2023
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive interim financial report for Oriola Oyj covering the period from January 1 to September 30, 2023. It contains detailed financial statements, key performance indicators, management commentary, and market analysis. It is not a short announcement or a certification, but the full interim report itself, which fits the definition of an Interim / Quarterly Report (IR). 9M 2023
2023-10-31 Finnish

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.